Hogan Lovells has announced Kenneth W. Field, former antitrust partner and co-chair of the global Health Care Practice at Jones Day, as the new leader of the health care antitrust practice and a partner in Hogan Lovells’ Global Regulatory & Intellectual Property, Media & Technology (IPMT) practice group in Washington, D.C.
“We are delighted to welcome Ken to the firm,” said Janice Hogan, Global Head of Hogan Lovells’ Global Regulatory & IPMT practice group. “As a nationally recognized leader in both antitrust and health care law, Ken’s addition builds on our strategic commitment as one of Washington, D.C.’s top regulatory firms to grow and maintain the strength of our key practices.”
Read more: Hogan Lovells And Shearman & Sterling End Merger Talks
Field, who will be part of the firm’s Antitrust, Competition, and Economic Regulation (ACER) practice area, advises clients across the antitrust and competition law sectors before the United States Department of Justice (DOJ), Federal Trade Commission (FTC), and relevant state antitrust enforcement authorities. He has a broad range of transactional and M&A experience, as well as a deep understanding of complex health care regulatory issues.
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan